Drugs / BCG
last change Jan 2023 re-read 2 minutes ago

BCG

Developed for
urinary bladder cancer

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
NCT05146635 Comparator Dec 2021 → Dec 2022 urinary bladder cancer Mansoura University Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as BCG ClinicalTrials.gov intervention name — accepted as the source's own label NCT05146635
Route Other “intravesical immunotherapy (BCG)” NCT05146635